Human T-cell leukemia virus type 1

Active Research Protocols

  1. 00-C-0030 РA Phase I/II Study of the Efficacy and Toxicity of Humanized Anti-Tac (Zenapaxª) in the Therapy of Tac-Expressing Adult T-Cell Leukemia
  2. 01-C-0038 – Collection of Blood, Bone Marrow, Tumor, or Tissue Samples from Patients with HIV Infection, KSHV Infection, Viral-Related Pre-Malignant Lesions, and/or Cancer
  3. 03-C-0194 – Phase II Study of the Efficacy and Toxicity of Campath-1H in the Therapy of Adult T-Cell Leukemia
  4. 04-N-0071 – Phase I/II Study of HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Using the Humanized MiK-Beta-1 Monoclonal Antibody Directed Toward the IL-2/IL-15R-Beta Subunit (CD122) that Blocks IL-15 Action
  5. 09-C-0025 – Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia
  6. 13-C-0006 – Phase II Trial Evaluating the Safety and Efficacy of Ruxolitinib in Patients with Smoldering and Chronic Adult T-cell Leukemia (ATL)
  7. 13-N-0135 – Pilot Study of Raltegravir, an Integrase Inhibitor, in Human T-Cell Lymphotrophic Virus-1(HTLV-1) Associated Myelopathy, Tropical Spastic Paraparesis (HAM/TSP)
  8. 97-C-0143 – Collection of Blood, Bone Marrow and Tissue Samples for the Investigation of the Human Immune Response, Lymphoma Biology and HTLV-1 Infection
  9. 98-N-0047 – Immuno-Virological Evaluation of Human T Cell Leukemia Virus Type-1 Associated Myelopathy (HAM/TSP)
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014